In that way, seven hub genes ANXA1, VCAN, GPC3, TNC, IGFBP7, MATN3, and SPARCL1 were suggested as a key genes that may served as potential therapeutic targets for FECD [80]. This evidence concerns the gene TNC and Fuchs endothelial corneal dystrophy.